Molecular Diagnostics Market

Molecular Diagnostics Market, by Product Type (Reagents & Kits and Instruments), By Application (Oncology, Genetic Testing, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Labs, and Other) - Global Industry Insights, and Forecast to 2025

Report code : CMI21545 |
Industry :
Clinical Diagnostic

Published On : Apr 2018 |
Pages : 176 Pages |
Format :

Molecular Diagnostics Market - Global Industry Insights

Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA, which may be associated with disease. The disturbance between a single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others factors lead to various diseases. Disease that are diagnosed by using molecular diagnostic test includes infectious diseases, oncology, virology, and STDs.

Molecular diagnostics are capable of detecting specific disease which helps in providing precision medicine to patients. Government of various economies are focused on research and development of precision medicine, which is expected to drive growth of the molecular diagnostics market over the forecast period. For instance, in 2015, the U.S. government launched Precision Medicine Initiative (PMI), to increase awareness regarding advancement in the precision medicine field.

High prevalence of infectious disease and increasing incidences of cancer are expected to be the major factor fueling growth of the market over forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, around 5,251 deaths were reported due to influenza infection in the U.S. Furthermore, according to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S. with an estimated 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024.

The molecular diagnostics market is estimated to be valued at US$8,623.2 Mn in 2017 and is expected to witness a robust CAGR of 11.5% during the forecast period (2017-2025).

Molecular Diagnostics Market Share, By Product Type (%)

Source: Coherent Market Insights (2018)

Growth in biomarker identification is expected to foster growth of the molecular diagnostics market

Application of biomarkers in molecular diagnostic is increasing, due to advantages of biomarkers such as aiding in early detection of specific diseases. For instance, biomarkers are used in detection of ABO haemolytic diseases in new born, Huntington's disease and hereditary haemochromatosis, and cystic fibrosis. Biomarkers are also used in detection of disorders related to chromosome structure such as Turner syndrome, Down syndrome, patau syndrome, and Edwards’s syndrome. Furthermore, biomarker also have wide application in therapeutic areas, which includes neurological diseases, metabolic disorders, immune deregulation, and oncology.

Increasing research and development for identification of biomarkers have led to development of new molecular diagnostic tests, which is expected to foster growth of the molecular diagnostics market. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkes, Inc. for the first diagnostic blood test, for traumatic brain injury, Banyan BTI. Such innovations for various disease indication is expected to drive growth of the molecular diagnostics market in the near future.

Regional insights

North America accounts for the largest share in the global molecular diagnostics market and this is attributed to increasing adoption of precision medicine and growing prevalence of cancer. According to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024, in turn increasing the demand of the molecular diagnostics market in the near future.

Furthermore, the U.S. government, in 2015, launched Precision Medicine Initiative that aimed to revolutionize the treatment to improve health, as precision medicine provides an innovative approach that takes into account an individual’s differences in genes and offers tailored treatment. Precision Medicine Initiative have led to development of novel products and several new treatments are tailored for specific characteristic such as, person’s genetic makeup or genetic profile of an individual tumor that helps to transform the way of treatment. The Precision Medicine Initiative was valued at US$ 215 million in 2016 that could accelerate biomedical research and provide clinicians with new tools to select the innovative therapies tailored according to individual needs that, in turn favors, growth of the market of molecular diagnostic.

Key players in the market are involved in new product launches to cater to increasing demand for molecular diagnostic. For instance, in August 2016 Abbott Laboratories introduced Alinity, a next generation system, used for immunoassay, clinical chemistry, point-of-care, hematology, blood and plasma screening, and molecular diagnostics. Some of the other key players in the global molecular diagnostics market include Hologic,Inc., Grifols, S.A., Abbott Laboratories, Qiagen N.V., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, and Beckman Coulter, Inc.

Request Sample Request Customization

Molecular diagnostics is used for detection in various applications such as oncology, genetic testing, microbiology, STDs, blood screening, virology, tissue typing, and prenatal diagnostics. Molecular diagnostics are laboratory tests, conducted to identify a disease by analyzing DNA, RNA or proteins in humans. Furthermore, the reagent and kits for molecular diagnostics kits vary according to the application, as the kits consists of probes that are directed against specific sequence of viruses, bacteria, and parasites. Increasing use of biomarker specific testing kits is expected to foster growth of the molecular diagnostics market, as these tests are useful prior to initiation of any therapy or treatment.

Market Dynamics

The global molecular diagnostics market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel biomarkers. For instance, in June 2017, Qiagen N.V. expanded its biomarker content portfolio by adding new biomarkers for microsatellite instability (MSI) and Mismatch repair (MMR) in its NGS panels. This extension in the product portfolio was done to cater to growing demand for molecular diagnostics for immuno-oncology therapies.

Furthermore, precision medicine aids in treatment of diseases and prevention based on individual’s genes, lifestyle, and environment. This helps to offer proper treatment, which has led to high demand for precision medicine, in turn, favoring growth of the market.

However, stringent regulation by FDA to regulate molecular diagnostic tests is expected to be major factor restraining growth of the market. The FDA regulates molecular diagnostic tests in various ways, including in some instances, wherein, certain tests require regulatory pathways as complex as Class III medical devices.

Key features of the study:

This report provides in-depth analysis of the molecular diagnostics market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global molecular diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Hologic,Inc., Grifols, S.A., Qiagen N.V., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, and Beckman Coulter, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics.
The global molecular diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for molecular diagnostics market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

Global Molecular Diagnostics Market, By Product Type:

Reagents & Kits (Consumables)
Instruments

Global Molecular Diagnostics Market, By Application

Oncology
Genetic Testing
Microbiology
STDs
Blood Screening
Virology
Tissue Typing
Prenatal Diagnosis
Others

Global Molecular Diagnostics Market, By End User:
- Hospitals
- Diagnostic Laboratories
- Academic and Research Labs
- Others
Global Molecular Diagnostics Market, By Region:
- North America
  - North America Molecular Diagnostics Market, By Product Type
    - Reagents & Kits (Consumables)
    - Instruments
  - North America Molecular Diagnostics Market, By Application
    - Oncology
    - Genetic Testing
    - Microbiology
    - STDs
    - Blood Screening
    - Virology
    - Tissue Typing
    - Prenatal Diagnosis
    - Others
  - North America Molecular Diagnostics Market, By End User
    - Hospitals
    - Diagnostic Laboratories
    - Academic and Research Labs
    - Other
  - North America Molecular Diagnostics Market, By Country
    - U.S.
    - Canada
- Europe
- Asia Pacific
  - Asia Pacific Molecular Diagnostics Market, By Product Type
    - Reagents & Kits (Consumables)
    - Instruments
  - Asia Pacific Molecular Diagnostics Market, By Application
    - Oncology
    - Genetic Testing
    - Microbiology
    - STDs
    - Blood Screening
    - Virology
    - Tissue Typing
    - Prenatal Diagnosis
    - Others
  - Asia Pacific Molecular Diagnostics Market, By End User
    - Hospitals
    - Diagnostic Laboratories
    - Academic and Research Labs
    - Other
  - Asia Pacific Molecular Diagnostics Market, By Country
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Latin America Molecular Diagnostics Market, By Product Type
    - Reagents & Kits (Consumables)
    - Instruments
  - Latin America Molecular Diagnostics Market, By Application
    - Oncology
    - Genetic Testing
    - Microbiology
    - STDs
    - Blood Screening
    - Virology
    - Tissue Typing
    - Prenatal Diagnosis
    - Others
  - Latin America Molecular Diagnostics Market, By End User
    - Hospitals
    - Diagnostic Laboratories
    - Academic and Research Labs
    - Other
  - Latin America Molecular Diagnostics Market, By Country
    - Brazil
    - Mexico
    - Rest of Latin America
- Middle East
  - Middle East Molecular Diagnostics Market, By Product Type
    - Reagents & Kits (Consumables)
    - Instruments
  - Middle East Molecular Diagnostics Market, By Application
    - Oncology
    - Genetic Testing
    - Microbiology
    - STDs
    - Blood Screening
    - Virology
    - Tissue Typing
    - Prenatal Diagnosis
    - Others
  - Middle East Molecular Diagnostics Market, By End User
    - Hospitals
    - Diagnostic Laboratories
    - Academic and Research Labs
    - Other
  - Middle East Molecular Diagnostics Market, By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Africa Molecular Diagnostics Market, By Product Type
    - Reagents & Kits (Consumables)
    - Instruments
  - Africa Molecular Diagnostics Market, By Application
    - Oncology
    - Genetic Testing
    - Microbiology
    - STDs
    - Blood Screening
    - Virology
    - Tissue Typing
    - Prenatal Diagnosis
    - Others
  - Africa Molecular Diagnostics Market, By End User
    - Hospitals
    - Diagnostic Laboratories
    - Academic and Research Labs
    - Other
  - Africa Molecular Diagnostics Market, By Country
    - North Africa
    - Central Africa
    - South Africa
Company Profiles
- Abbott Laboratories *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Hologic, Inc.
- Grifols, S.A.
- Qiagen N.V.
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- Becton, Dickinson and Company
- Beckman Coulter, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Request Sample Request Customization

Table of Contents

Research Objective and assumption

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet Product Type
Market Snippet By Application
Market Snippet By End-User
Market Snippet By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities

Epidemiology
Key Developments
Reimbursement
PEST Analysis

Global Molecular Diagnostics Market, Product Type, 2015 - 2025 (USD Million)

Introduction

Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2016 - 2025
Segment Trends

Reagents & Kits

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Instruments

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Global Molecular Diagnostics Market, By Application, 2015 - 2025 (USD Million)

Introduction

Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2016 - 2025
Segment Trends

Oncology

Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2016 - 2025

Genetic Testing

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

STDs

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Microbiology

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Blood Screening

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Virology

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Tissue Typing

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Prenatal Diagnosis

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Others

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Global Molecular Diagnostics Market, By End-User, 2015 - 2025 (USD Million)

Introduction

Market Share Analysis, 2017 and 2025 (%)
Y-O-Y Growth Analysis, 2016 - 2025
Segment Trends

Hospitals

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Diagnostic Laboratories

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Academic and Research Labs

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Others

Introduction
Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (USD Million)

Global Molecular Diagnostics Market, By Regions, 2015 - 2025 (USD Million)

Introduction

Market Share Analysis, By Product Type, 2017 and 2025 (%)
Market Share Analysis, By Application, 2017 and 2025 (%)
Market Share Analysis, By End User, 2017 and 2025 (%)
Market Share Analysis, By Region, 2017 and 2025 (%)
Y-O-Y Growth Analysis, For Regions, 2015 - 2025

North America

Market Size and Forecast, By Product Type, 2017 and 2025 (%)
Market Size and Forecast, By Application, 2017 and 2025 (%)
Market Size and Forecast, By End User, 2017 and 2025 (%)
Market Size and Forecast, By Country, 2017 and 2025 (%)

U.S.
Canada

Europe

Market Size and Forecast, By Product Type, 2017 and 2025 (%)
Market Size and Forecast, By Application, 2017 and 2025 (%)
Market Size and Forecast, By End User, 2017 and 2025 (%)
Market Size and Forecast, By Country, 2017 and 2025 (%)

U.K.
Germany
Italy
France
Russia
Others

Asia Pacific

Market Size and Forecast, By Product Type, 2017 and 2025 (%)
Market Size and Forecast, By Application, 2017 and 2025 (%)
Market Size and Forecast, By End User, 2017 and 2025 (%)
Market Size and Forecast, By Country, 2017 and 2025 (%)

China
India
Japan
ASEAN
Australia
South Korea
Others

Latin America

Market Size and Forecast, By Product Type, 2017 and 2025 (%)
Market Size and Forecast, By Application, 2017 and 2025 (%)
Market Size and Forecast, By End User, 2017 and 2025 (%)
Market Size and Forecast, By Country, 2017 and 2025 (%)

Brazil
Argentina
Mexico
Others

Middle East

Market Size and Forecast, By Product Type, 2017 and 2025 (%)
Market Size and Forecast, By Application, 2017 and 2025 (%)
Market Size and Forecast, By End User, 2017 and 2025 (%)
Market Size and Forecast, By Country, 2017 and 2025 (%)

GCC Countries
Israel
Rest of Middle East

Africa

Market Size and Forecast, By Product Type, 2017 and 2025 (%)
Market Size and Forecast, By Application, 2017 and 2025 (%)
Market Size and Forecast, By End User, 2017 and 2025 (%)
Market Size and Forecast, By Country, 2017 and 2025 (%)

North Africa
Central Africa
South Africa

Competitive Landscape

Heat Map Analysis
Company Profiles

Abbott Laboratories

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Hologic, Inc.

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Grifols, S.A.

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Qiagen, N.V.

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

F. Hoffmann-La Roche Ltd.

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Siemens Healthineers

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Becton, Dickinson and Company

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Beckman Coulter, Inc.

Company Overview
Product Description
Financial Performance
Recent Developments
Strategies

Analyst Views

Section

References
Research Methodology
About us and Sales Contact

*Browse 37 market data tables and 35 figures on “Molecular Diagnostics Market” - Global forecast to 2025”

Request Sample Request Customization

Related Insights :

Veterinary Chemistry Analyzers Market Size, 2026 | Industry Report

Pregnancy Testing Devices Market Size, Trends Till 2026

ESR Analyzer Market Size, Trend and Forecast Till 2026

Precision Medicine Diagnostics Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Meningitis Diagnostic Testing Market Size, Share Till 2026

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.
Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.
Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.
Assured Quality

We strive to provide most accurate and reliable research findings in our research reports.

Clinical Diagnostic

Source: Coherent Market Insights (2018)

Related Insights :

Share

Choose License Type

"How Can I Help You" ?

Key Benefits

Custom Research Solution

Customer Fulfilment

Quick Turnaround Time Reports

360-degree Approach

Assured Quality